MedTrace Logo

Oral Tranexamic Acid and Topical Hydroquinone in the Treatment of Melasma

NCT03751163 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-11-26

No results posted yet for this study

Summary

This study assess the effectiveness of oral tranexamic acid in combination with hydroquinone cream in the treatment of melasma.

Conditions

  • Melasma

Interventions

DRUG

Tranexamic Acid Oral Product

Encapsulated tranexamic acid 250 mg

DRUG

Hydroquinone 4% Cream

Hydroquinone 4% Cream

OTHER

Sunscreen

Sunscreen SPF 30

DEVICE

Placebo

Encapsulated placebo

Sponsors & Collaborators

  • Fakultas Kedokteran Universitas Indonesia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-16
Primary Completion
2017-04-02
Completion
2017-04-02

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03751163 on ClinicalTrials.gov